𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypokinesia in Huntington's disease

✍ Scribed by Jeroen P. P. van Vugt; Bob J. van Hilten; Dr. Raymund A. C. Roos


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
483 KB
Volume
11
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Motor activity was quantitatively assessed over a period of 5 days using a wrist‐worn activity monitor in 14 patients with Huntington's disease (of whom 4 used neuroleptic drugs) and 14 age and sex‐matched healthy controls. Additionally, patients were rated for dementia, depression, clinical impairment of motor tasks, chorea, and disability. A significant decrease in daytime motor activity was observed in patients compared with controls, suggesting hypokinesia rather than hyperkinesia. Hypokinesia tended to be more severe in patients using neuroleptic drugs. Lower activity levels were significantly related to lower scores of functional disability, but not to other clinical measures. We conclude that hypokinesia is a prominent manifestation in Huntington's disease that is worsened by the use of neuroleptics.


πŸ“œ SIMILAR VOLUMES


Hypokinesia in Huntington's disease co-o
✍ Nanda Reedeker; Rose C. Van Der Mast; Erik J. Giltay; Erik Van Duijn; Raymond A. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 193 KB

## Abstract Besides chorea, hypokinesia is an important motor disturbance in Huntington's disease (HD) but its clinical, neuropsychiatric, and cognitive functioning correlates are largely unknown. This cross‐sectional study investigates correlates of hypokinesia in HD and its effect on global funct

Huntington's disease
✍ David Craufurd πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 873 KB

Huntington's disease (HD) is a late-onset degenerative disorder of the central nervous system, caused by a dominantly inherited mutation in a gene on chromosome 4p. The identification of the trinucleotide repeat mutation responsible for this disorder has been an important step towards understanding

Bruxism in Huntington's disease
✍ Eng-King Tan; Joseph Jankovic; William Ondo πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 1 views
Zotepine in Huntington's disease
✍ Raphael M. Bonelli; Gerald Niederwieser; Theresa Lahousen; Peter Hofmann πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 72 KB

## Abstract The authors report a patient with Huntington's disease (HD) presenting with severe chorea. The motor scale of the unified HD rating scale (UHDRS‐I) revealed 81 points. Motor function clearly improved with zotepine, until she reached an UHDRS‐I of 34 points on day 7 of treatment. The pat

Bruxism in Huntington's disease
✍ Elan D. Louis; Elizabeth Tampone πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 13 KB
Weight loss in Huntington's disease
✍ Nicholas Stoy; Eileen McKay πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 176 KB πŸ‘ 2 views